Gallery of new files
Jump to navigation
Jump to search
This special page shows the last uploaded files.
-
Bismuth Subnitrate Package and Label Display Panel.jpg Imam Ali Shah
11:08, 27 March 2024
460 × 500; 181 KB
-
Effects of hepatic impairment and renal impairment on daridorexant PK.png Edzelco
21:07, 31 January 2024
1,230 × 788; 248 KB
-
Effect of daridorexant on the PK of other compounds.png Edzelco
21:07, 31 January 2024
1,250 × 1,086; 543 KB
-
Effect of co-administered compounds on the PK of daridorexant.png Edzelco
21:06, 31 January 2024
1,274 × 1,096; 454 KB
-
Allergic bronchopulmonary aspergillosis.gif Laith Adnan Allaham
13:10, 7 June 2023
407 × 440; 155 KB
-
Table 4 Clinical Data Trial 1 and 2.png Tejasvi Aryaputra
16:09, 20 January 2023
1,328 × 1,226; 254 KB
-
Ibrexafungerp Table 1 Adverse Reactions (Trials 1 and 2).png Tejasvi Aryaputra
16:09, 20 January 2023
1,296 × 516; 95 KB
-
Aducanumab-avwa Table 8 Study 2 Biomarkers.png Tejasvi Aryaputra
21:59, 10 January 2023
1,006 × 990; 196 KB
-
Aducanumab-avwa Table 7 Clinical Results Study 1.png Tejasvi Aryaputra
21:59, 10 January 2023
1,000 × 1,318; 214 KB
-
Aducanumab-avwa Table 6 Study 1 Biomarkers.png Tejasvi Aryaputra
21:59, 10 January 2023
1,350 × 1,318; 231 KB
-
Aducanumab-avwa Table 5 Adverse Reactions.png Tejasvi Aryaputra
21:59, 10 January 2023
1,314 × 1,256; 214 KB
-
Aducanumab-avwa Table 4 ARIA Classification.png Tejasvi Aryaputra
21:59, 10 January 2023
1,326 × 926; 176 KB
-
Aducanumab-avwa Table 3 Dosing Modifciations.png Tejasvi Aryaputra
21:58, 10 January 2023
1,308 × 748; 147 KB
-
Aducanumab-avwa Table 2 Dosing Monitoring.png Tejasvi Aryaputra
21:58, 10 January 2023
1,330 × 718; 136 KB
-
Aducanumab-avwa Figure 4 Clinical Studies.png Tejasvi Aryaputra
21:57, 10 January 2023
1,014 × 944; 305 KB
-
Aducanumab-avwa Figure 3 Clinical Studies.png Tejasvi Aryaputra
21:57, 10 January 2023
1,012 × 990; 219 KB
-
Aducanumab-avwa Figure 2 Clinical Studies.png Tejasvi Aryaputra
21:57, 10 January 2023
1,350 × 1,206; 268 KB
-
Aducanumab-avwa Figure 1 Clinical Studies.png Tejasvi Aryaputra
21:57, 10 January 2023
1,352 × 1,318; 350 KB
-
Aducanumab-avwa Drug Label (3 mL).png Tejasvi Aryaputra
21:56, 10 January 2023
1,362 × 1,100; 583 KB
-
Aducanumab-avwa Drug Label (1.7 mL).png Tejasvi Aryaputra
21:56, 10 January 2023
1,352 × 1,102; 578 KB
-
Rylaze Table 2 Dosage Modifications.png Tejasvi Aryaputra
13:46, 3 January 2023
1,006 × 1,498; 348 KB
-
Upper GI bleeding. Adapted from ACG Clinical Guideline- Upper Gastrointestinal and Ulcer Bleeding.png Jair Basantes de la Calle
13:54, 29 December 2022
1,920 × 1,080; 201 KB
-
Stage A and Stage B recommendations for HF. Adapted from 2022 AHA-ACC-HFSA Guideline for the Management of Heart Failure.png Jair Basantes de la Calle
21:21, 8 December 2022
1,920 × 1,080; 144 KB
-
Recommendation for blood pressure management. Adapted from the 2019 ACC-AHA Guideline on the Primary Prevention of Cardiovascular Disease. .png Jair Basantes de la Calle
19:24, 8 December 2022
1,920 × 1,080; 91 KB
-
Primary Prevention of ASCVD per age group.png Jair Basantes de la Calle
18:28, 8 December 2022
1,920 × 1,080; 318 KB
-
Diagnostic Algorithm for HF and EF-Based Classification.png Jair Basantes de la Calle
12:57, 28 November 2022
1,678 × 1,080; 171 KB
-
Finerenone Table 4 Clinical Studies.png Tejasvi Aryaputra
00:16, 6 September 2022
608 × 1,450; 175 KB
-
Finerenone Table 3 Adverse Reactions.png Tejasvi Aryaputra
00:15, 6 September 2022
1,004 × 656; 85 KB
-
Finerenone Table 2 Dosage Adjustments.png Tejasvi Aryaputra
00:15, 6 September 2022
1,142 × 898; 147 KB
-
Finerenone Figure 2 Clinical Studies.png Tejasvi Aryaputra
00:15, 6 September 2022
1,290 × 1,080; 519 KB
-
Finerenone Figure 1 Clincal Studies.png Tejasvi Aryaputra
00:15, 6 September 2022
1,326 × 1,158; 550 KB
-
Fexinidazole Table 5 Pharmocokinetics.png Tejasvi Aryaputra
02:11, 5 September 2022
640 × 1,514; 262 KB
-
Fexinidazole Table 4 Drug Interactions Pt.4.png Tejasvi Aryaputra
02:10, 5 September 2022
622 × 658; 133 KB
-
Fexinidazole Table 3 Drug Interactions Pt.1.png Tejasvi Aryaputra
02:10, 5 September 2022
612 × 1,028; 209 KB
-
Fexinidazole Table 2 Adverse Reactions Pt.2.png Tejasvi Aryaputra
02:10, 5 September 2022
610 × 546; 78 KB
-
Fexinidazole Table 2 Adverse Reactions.png Tejasvi Aryaputra
02:10, 5 September 2022
622 × 1,308; 188 KB
-
Belumosudil Table 2 Adverse Reactions.png Tejasvi Aryaputra
01:34, 30 August 2022
586 × 1,246; 135 KB
-
Belumosudil Table 2 Adverse Reactions Pt. 2.png Tejasvi Aryaputra
01:32, 30 August 2022
540 × 676; 136 KB
-
Odevixibat Table 3 Adverse Reactions.png Tejasvi Aryaputra
00:38, 25 August 2022
1,270 × 1,274; 218 KB
-
Odevixibat Package Label (1200 mcg).png Tejasvi Aryaputra
00:38, 25 August 2022
1,344 × 1,320; 470 KB
-
Odevixibat Package Label (600 mcg).png Tejasvi Aryaputra
00:38, 25 August 2022
1,348 × 1,448; 509 KB
-
Odevixibat Package Label (400 mcg).png Tejasvi Aryaputra
00:38, 25 August 2022
1,340 × 1,320; 471 KB
-
Odevixibat Package Label (200 mcg).png Tejasvi Aryaputra
00:38, 25 August 2022
1,344 × 1,446; 486 KB
-
•Prodrome weakness, malaise, myalgias, abdominal pain.png Hassan M
04:22, 7 August 2022
1,024 × 768; 106 KB
-
Anifrolumab-fnia Table 1 Adverse Reactions.png Tejasvi Aryaputra
18:22, 5 August 2022
1,312 × 1,370; 197 KB
-
Small-cell-lung-cancer-right-upper-lobe-collapse.jpg Hassan M
18:56, 31 July 2022
1,600 × 1,600; 245 KB
-
Avalglucosidase alfa-ngpt Table 5 Walking.png Tejasvi Aryaputra
18:51, 25 July 2022
1,216 × 970; 193 KB
-
Avalglucosidase alfa-ngpt Table 4 FVC.png Tejasvi Aryaputra
18:51, 25 July 2022
1,202 × 1,024; 208 KB
-
Avalglucosidase alfa-ngpt Table 3 Antibodies.png Tejasvi Aryaputra
18:50, 25 July 2022
612 × 856; 141 KB
-
Avalglucosidase alfa-ngpt Table 2 Adverse Reactions.png Tejasvi Aryaputra
18:50, 25 July 2022
1,204 × 1,162; 183 KB
-
Avalglucosidase alfa-ngpt Table 1 Infusion Rate.png Tejasvi Aryaputra
18:50, 25 July 2022
1,240 × 902; 134 KB
-
Avalglucosidase alfa-ngpt Packaging Label 2.png Tejasvi Aryaputra
18:50, 25 July 2022
646 × 156; 25 KB
-
Avalglucosidase alfa-ngpt Packaging Label.png Tejasvi Aryaputra
18:50, 25 July 2022
656 × 1,484; 230 KB
-
Avalglucosidase alfa-ngpt Figure 2 Walking.png Tejasvi Aryaputra
18:50, 25 July 2022
1,274 × 816; 238 KB
-
Avalglucosidase alfa-ngpt Figure 1 FVC.png Tejasvi Aryaputra
18:49, 25 July 2022
1,288 × 842; 241 KB
-
Avalglucosidase alfa-ngpt Drug Packaging.png Tejasvi Aryaputra
18:49, 25 July 2022
1,334 × 1,410; 713 KB
-
Belzutifan Table 3 Lab Abnormalities.png Tejasvi Aryaputra
18:55, 21 July 2022
1,192 × 1,210; 163 KB
-
Giemsa stain of bone marrow biopsy showing sheets of plasma cells..jpg Ariwoola Azeezat Oyetola
12:03, 21 July 2022
960 × 720; 191 KB
-
Difelikefalin Table 2 Adverse Reactions.png Tejasvi Aryaputra
20:14, 12 July 2022
1,328 × 1,196; 189 KB
-
Lonapegsomatropin-tcgd Table 6 Catridges.png Tejasvi Aryaputra
12:36, 5 July 2022
1,126 × 818; 92 KB
-
Lonapegsomatropin-tcgd Table 5 Height SDS.png Tejasvi Aryaputra
12:36, 5 July 2022
1,208 × 750; 128 KB
-
Lonapegsomatropin-tcgd Table 4 High Velocity.png Tejasvi Aryaputra
12:36, 5 July 2022
1,192 × 834; 163 KB
-
Lonapegsomatropin-tcgd Table 3 Drug Interactions.png Tejasvi Aryaputra
12:36, 5 July 2022
614 × 1,262; 255 KB
-
Lonapegsomatropin-tcgd Table 2 Adverse Reactions.png Tejasvi Aryaputra
12:35, 5 July 2022
1,272 × 1,132; 207 KB
-
Lonapegsomatropin-tcgd Drug Label 13.3 Mg Pt.2.png Tejasvi Aryaputra
12:35, 5 July 2022
1,326 × 1,168; 602 KB
-
Lonapegsomatropin-tcgd Drug Label 13.3 Mg Pt.1.png Tejasvi Aryaputra
12:35, 5 July 2022
1,298 × 712; 341 KB
-
Lonapegsomatropin-tcgd Drug Label 11 Mg Pt.2.png Tejasvi Aryaputra
12:35, 5 July 2022
1,316 × 1,178; 603 KB
-
Lonapegsomatropin-tcgd Drug Label 11 Mg Pt.1.png Tejasvi Aryaputra
12:35, 5 July 2022
1,320 × 718; 340 KB
-
Lonapegsomatropin-tcgd Drug Label 9.1 Mg Pt.2.png Tejasvi Aryaputra
12:33, 5 July 2022
1,316 × 1,186; 604 KB
-
Lonapegsomatropin-tcgd Drug Label 9.1 Mg Pt.1.png Tejasvi Aryaputra
12:33, 5 July 2022
1,284 × 720; 341 KB
-
Lonapegsomatropin-tcgd Drug Label 7.6 Mg Pt.2.png Tejasvi Aryaputra
12:32, 5 July 2022
1,326 × 1,192; 560 KB
-
Lonapegsomatropin-tcgd Drug Label 7.6 Mg Pt.1.png Tejasvi Aryaputra
12:32, 5 July 2022
1,304 × 726; 345 KB
-
Lonapegsomatropin-tcgd Drug Label 6.3 Mg Pt.2.png Tejasvi Aryaputra
12:32, 5 July 2022
1,328 × 1,178; 556 KB
-
Lonapegsomatropin-tcgd Drug Label 6.3 Mg Pt.1.png Tejasvi Aryaputra
12:31, 5 July 2022
1,292 × 726; 339 KB
-
Lonapegsomatropin-tcgd Drug Label 5.2 Mg Pt.2.png Tejasvi Aryaputra
12:31, 5 July 2022
1,324 × 1,186; 554 KB
-
Lonapegsomatropin-tcgd Drug Label 5.2 Mg Pt.1.png Tejasvi Aryaputra
12:31, 5 July 2022
1,320 × 730; 341 KB
-
Lonapegsomatropin-tcgd Drug Label 4.3 Mg Pt.2.png Tejasvi Aryaputra
12:31, 5 July 2022
1,328 × 1,196; 560 KB
-
Lonapegsomatropin-tcgd Drug Label 4.3 Mg Pt.1.png Tejasvi Aryaputra
12:30, 5 July 2022
1,318 × 720; 337 KB
-
Lonapegsomatropin-tcgd Drug Label 3.6 Mg Pt.2.png Tejasvi Aryaputra
12:29, 5 July 2022
1,318 × 1,190; 560 KB
-
Lonapegsomatropin-tcgd Drug Label 3.6 Mg Pt.1.png Tejasvi Aryaputra
12:29, 5 July 2022
1,306 × 724; 338 KB
-
Lonapegsomatropin-tcgd Drug Label 3 Mg Pt.2.png Tejasvi Aryaputra
12:29, 5 July 2022
1,316 × 1,178; 554 KB
-
Lonapegsomatropin-tcgd Drug Label 3 Mg Pt.1.png Tejasvi Aryaputra
12:29, 5 July 2022
1,268 × 732; 338 KB
-
Lonapegsomatropin-tcgd Drug Information Pt.6.png Tejasvi Aryaputra
12:29, 5 July 2022
654 × 492; 84 KB
-
Lonapegsomatropin-tcgd Drug Information Pt.5.png Tejasvi Aryaputra
12:28, 5 July 2022
660 × 1,314; 243 KB
-
Lonapegsomatropin-tcgd Drug Information Pt.4.png Tejasvi Aryaputra
12:28, 5 July 2022
666 × 1,418; 259 KB
-
Lonapegsomatropin-tcgd Drug Information Pt.3.png Tejasvi Aryaputra
12:28, 5 July 2022
658 × 1,224; 215 KB
-
Lonapegsomatropin-tcgd Drug Information Pt.2.png Tejasvi Aryaputra
12:28, 5 July 2022
664 × 1,318; 245 KB
-
Lonapegsomatropin-tcgd Drug Information Pt.1.png Tejasvi Aryaputra
12:28, 5 July 2022
670 × 1,416; 259 KB
-
Mobocertinib Table 4 Adverse Reactions Lab Abnormalties.png Tejasvi Aryaputra
20:18, 15 June 2022
1,326 × 1,626; 270 KB
-
Mobocertinib Table 3 Adverse Reactions.png Tejasvi Aryaputra
20:18, 15 June 2022
660 × 1,268; 157 KB
-
Mobocertinib Table 2 Dosage for Adverse Reactions Pt.2.png Tejasvi Aryaputra
20:17, 15 June 2022
646 × 812; 122 KB
-
Mobocertinib Table 2 Dosage for Adverse Reactions.png Tejasvi Aryaputra
20:17, 15 June 2022
660 × 1,254; 215 KB
-
Acute Interstitial Pneumonitis Chest Xray - Case Courtesy of Dr Salam, Radiopaedia, rID 45404.jpeg Nnabude
04:32, 5 May 2022
630 × 586; 45 KB
-
Congenital-diaphragmatic-hernia-right-sided-1.jpg AroojNaz
08:18, 23 April 2022
1,631 × 1,129; 197 KB
-
Endometrial-polyp-with-complex-hyperplasia-and-atypia-pathology-2.jpg AroojNaz
11:29, 9 March 2022
2,520 × 1,899; 1.62 MB
-
Endometrial-polyp-with-complex-hyperplasia-and-atypia-pathology.jpg AroojNaz
11:28, 9 March 2022
1,716 × 1,914; 812 KB
-
Endometrial-carcinoma-in-premenopausal-woman.png AroojNaz
10:33, 9 March 2022
1,556 × 1,002; 1.42 MB
-
Tisotumab vedotin-tftv Packaging Label.png Tejasvi Aryaputra
02:29, 27 January 2022
640 × 1,324; 175 KB
-
Tisotumab vedotin-tftv Drug Packaging .png Tejasvi Aryaputra
02:28, 27 January 2022
1,322 × 1,316; 1,003 KB
-
Tisotumab vedotin-tftv Table 7 Efficacy.png Tejasvi Aryaputra
02:28, 27 January 2022
1,238 × 854; 109 KB
-
Tisotumab vedotin-tftv Table 6 Pharmacodynamics.png Tejasvi Aryaputra
02:28, 27 January 2022
976 × 452; 85 KB
-
Tisotumab vedotin-tftv Table 2 Adverse Reactions.png Tejasvi Aryaputra
02:27, 27 January 2022
662 × 1,458; 268 KB
-
Tisotumab vedotin-tftv Table 3 Storage.png Tejasvi Aryaputra
02:27, 27 January 2022
1,038 × 634; 101 KB
-
Tisotumab vedotin-tftv Table 5 Lab Data.png Tejasvi Aryaputra
02:26, 27 January 2022
640 × 916; 118 KB
-
Tisotumab vedotin-tftv Table 4 Adverse Reactions.png Tejasvi Aryaputra
02:26, 27 January 2022
656 × 1,488; 144 KB
-
Tisotumab vedotin-tftv Table 1 Dose Schedule.png Tejasvi Aryaputra
02:26, 27 January 2022
796 × 474; 59 KB
-
Atogepant Figure 4 Distribution of Baseline.png Tejasvi Aryaputra
23:18, 19 January 2022
1,300 × 766; 352 KB
-
Atogepant Table 4 Study 2 Efficacy .png Tejasvi Aryaputra
23:18, 19 January 2022
1,308 × 982; 148 KB
-
Atogepant Figure 2 Distribution Change.png Tejasvi Aryaputra
23:17, 19 January 2022
1,312 × 978; 540 KB
-
Atogepant Table 1 Dosage Modifications.png Tejasvi Aryaputra
23:11, 19 January 2022
1,180 × 696; 129 KB
-
Maralixibat Table 3 Clinical Trial Data.png Tejasvi Aryaputra
03:29, 17 January 2022
1,006 × 624; 101 KB
-
Maralixibat Table 2 Adverse Reactions.png Tejasvi Aryaputra
03:28, 17 January 2022
686 × 1,404; 330 KB
-
Avacopan Drug Packaging 30 Tablets.png Tejasvi Aryaputra
00:54, 11 January 2022
1,314 × 1,216; 621 KB
-
Avacopan Figure 1 Sustained Remission.png Tejasvi Aryaputra
00:49, 11 January 2022
1,324 × 1,454; 457 KB
-
Avacopan Table 4 Sustained Remission.png Tejasvi Aryaputra
00:49, 11 January 2022
1,282 × 824; 175 KB
-
Avacopan Table 3 Pharmacokinetcis Changes.png Tejasvi Aryaputra
00:48, 11 January 2022
1,288 × 758; 147 KB
-
Avacopan Table 2 Pharmacokinetics with M1.png Tejasvi Aryaputra
00:48, 11 January 2022
1,290 × 936; 174 KB
-
Avacopan Table 1 Adverse Reactions.png Tejasvi Aryaputra
00:38, 11 January 2022
1,272 × 1,244; 191 KB
-
Pneumococcal-pneumonia-complication-parapneumonic-effusion-1.png AroojNaz
10:58, 10 January 2022
512 × 512; 259 KB
-
Asciminib Table 5 Adverse Reactions .png Tejasvi Aryaputra
21:45, 5 January 2022
674 × 1,282; 219 KB